DELLA CHIESA, MARIELLA
 Distribuzione geografica
Continente #
EU - Europa 6.801
Totale 6.801
Nazione #
IT - Italia 6.801
Totale 6.801
Città #
Genova 4.917
Rapallo 696
Genoa 627
Vado Ligure 544
Bordighera 17
Totale 6.801
Nome #
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 184
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 164
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues. 152
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? 148
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 148
Markers and function of human NK cells in normal and pathological conditions 148
NK cells and their receptors during viral infections. 144
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 143
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 141
Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections 138
Features of Memory-Like and PD-1+ Human NK Cell Subsets 135
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. 132
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 131
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2 130
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses 129
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 128
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia 127
Pathogen-induced private conversations between natural killer and dendritic cells 126
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 126
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 121
Natural killer lymphocytes: "null cells" no more. 120
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 119
Impact of HCMV Infection on NK Cell Development and Function after HSCT. 118
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells 118
Human NK cell response to pathogens 115
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 113
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 111
COMPOSITIONS AND METHODS FOR REGULATING NK CELL ACTIVITY 110
Shaping of adaptive immunity by innate interactions 106
Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation 105
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function 103
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 103
It's only innate immunity but I like it 103
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 102
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 102
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 101
Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. 95
The NK/DC complot 95
Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies 92
NK Cell-Based Immunotherapy for Hematological Malignancies 91
CMV induces rapid NK cell maturation in HSCT recipients. 88
IL-12 or IL-4 prime human natural killer cells to mediate functionally divergent interactions with dendritic cells or tumors 86
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 83
IL-12 or IL-4 prime human Natural Killer cells to mediate functionally divergent interactions with Dendritic cells or tumors 82
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. 80
IL-12 or IL-4 prime human Natural Killer Cells to mediate functionally diverent interactions with dendritic cells or tumors 79
Pan-KIR2DL NK -receptor antibodies and their use in diagnostik and therapy 78
Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content 77
ANTIBODIES BINDING TO RECEPTORS KIR2DL1, -2, 3 BUT NOT KIR2DS4 AND THEIR THERAPEUTIC USE 75
Pan-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy 75
The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells 73
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 73
In the thick of the fray: NK cells in inflamed tissues 73
Pan-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy 70
NK-DC intercourse during inflammation 70
TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences for the NK-mediated killing of dendritic cells 70
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. 65
Influence of human cytomegalovirus reactivation on NK-cell reconstitution in patients given haploidentical T-cell depleted HSCT and umbilical cord blood transplantation 63
The NK/DC complot 62
The tryptophan catabolite L-Kynurenine affects human NK cell function 59
NK Cell-Based Immunotherapy in Colorectal Cancer 58
Compositions and Methods for Regulating NK Cell Activity 57
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer 54
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 54
Neutrophilic priming of NK cells enhance the response to ensuing IL-12 stimulation 50
Phenotypic and functional heterogeneity of human NK cells developing after intrabone umbilical cord blood transplantation: a role for human cytomegalovirus? 47
Human NK cells, their receptors and function 45
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma 41
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 35
NK cells and ILCs in tumor immunotherapy 34
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 26
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 24
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 17
Anti-CD94-induced expansion of highly functional adaptive NKG2C+NKG2A−CD57+selfKIR+ NK cells from CMV-seropositive healthy donors 17
Proteomic characterization of human CMV-driven adaptive NK cells 7
In depth characterization of human CMV-driven adaptive NK cells through mass spectrometry and flow cytometry analyses 7
Totale 6.971
Categoria #
all - tutte 21.892
article - articoli 18.421
book - libri 0
conference - conferenze 1.260
curatela - curatele 0
other - altro 0
patent - brevetti 1.282
selected - selezionate 0
volume - volumi 929
Totale 43.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.451 0 0 0 0 163 194 260 123 167 301 192 51
2020/2021608 36 53 52 43 21 64 56 41 75 68 49 50
2021/2022891 46 75 84 87 21 59 57 188 48 80 49 97
2022/2023862 81 78 11 91 117 150 1 68 153 3 92 17
2023/2024474 33 56 9 70 42 49 21 36 28 32 27 71
2024/2025559 40 104 58 121 236 0 0 0 0 0 0 0
Totale 6.971